BAJAJ BROKING

Notification
No new Notification messages
Inventurus Knowledge Solutions IPO is Open!
Apply for the Inventurus Knowledge Solutions IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

Zenith Drugs Ltd

Pharmaceuticals

Offer Period :

19th to 22nd Feb 2024

Zenith Drugs Limited, founded in 2000, focuses on producing and distributing high-quality, affordable pharmaceuticals, adhering to WHO-GMP standards and holding ISO 9001:2015 certification. Their product line includes ORS Powder, Liquid Orals, Ointments, Liquid Externals, and Capsules,Read more... with over 600 FDA-approved products. They're establishing a new manufacturing facility in Indore, MP, and offer third-party manufacturing services. Employing 89 individuals as of March 31, 2023.Read less

Zenith Drugs Ltd IPO Details

IPO Date 19th to 22nd Feb 2024 Minimum Investment ₹126400 / 1 Lots
Listing Date 2024-02-27 Maximum Investment ₹126400 / 1 Lots
Face Value ₹10 per share Total Issue Size ₹40.68 Crores
Price ₹79 to ₹79 per share Fresh Issue ₹40.68 Crores
Lot Size 1 Lots (1600 Shares) Offer For Sale ₹ 0
Listing At NSE-SME Retail Discount ₹ 0
Employee Discount ₹0 per share    
IPO Date 19th to 22nd Feb 2024
Listing Date 2024-02-27
Face Value ₹10 per share
Price ₹79 to ₹79 per share
Lot Size 1 Lots (1600 Shares)
Listing At NSE-SME
Employee Discount ₹0 per share
Minimum Investment ₹126400 / 1 Lots
Maximum Investment ₹126400 / 1 Lots
Total Issue Size ₹40.68 Crores
Fresh Issue ₹40.68 Crores
Offer For Sale
Retail Discount ₹ 0

Timeline

Important dates for allocation and IPO listing.

19th Feb

IPO Starts

22nd Feb

IPO Ends

23rd Feb

Allotment Date

26th Feb

Initiation of Refund

26th Feb

Credit of Shares to Demat Account

27th Feb

IPO Listing Date

Shareholder Pattern

  Pre-Issue Post-Issue
Promoter Group 91.58 64.09
Public Group 8.42 35.91

Zenith Drugs Ltd IPO Reservation

QIB Shares Offered 2147200(41.7%)
NII (HNI) Shares Offered 644800(12.52%)
Retail Shares Offered 1504000(29.21%)
Anchor Investor Shares Offered 0(0%)
Total Shares Offered 5148800
Total Shares With Anchor Investor 5148800

IPO Lot Size

ApplicationLotsSharesAmount
Retail (Min)---
Retail (Max)---
S-HNI (Min)---
S-HNI (Max)---

Zenith Drugs Ltd IPO Registrar

Bigshare Services Pvt Ltd
Phone Number +91 - 22 - 6263 8200;
Email Id ipo@bigshareonline.com
Our Website www.bigshareonline.com

Zenith Drugs Ltd IPO Lead Manager

1. Gretex Corporate Services Ltd

Explore IPOs


Explore comprehensive IPO details for every IPO. Access essential information such as listing price, listing date, issue price, lot size, issue size, minimum investment, and IPO timeline. Gain insights into the company's background, strengths, and potential risks. Track the subscription status and delve into the financials of the company, empowering yourself with crucial data for informed investment decisions. Stay ahead in the dynamic IPO market by staying informed on upcoming, ongoing, and past IPOs. 
 

Stay ahead in the ever-evolving IPO landscape with our comprehensive platform. We offer a holistic resource, ensuring you not only access essential details but also gain valuable insights into market trends. Navigate confidently, armed with intricate analyses, expert opinions, and real-time updates. Whether you're a seasoned investor or a novice, our user-friendly interface and extensive information empower you to make well-informed decisions. Experience the convenience of having a dedicated space where you can delve into the intricacies of IPOs, enabling a strategic and calculated approach to the dynamic stock market. 

Zenith Drugs Ltd IPO Subscription LIVE Status

Category No. of shares offered No. of shares bid No. of subscribed

Strength of Zenith Drugs Ltd

1. Experienced Promoters and Management Team.

2. Cost Efficiency.

3. Formulation & Development.

4. Regulatory Compliance.

5. Global Reach.

6. Product Portfolio.

7. Supply Chain Efficiency.

8. Scalable Business Model.

9. Strong sales, marketing, and distribution capabilities.

Risks Involved

1. There are outstanding legal proceedings involving the Company, Promoters and Directors. Any adverse decision in such proceeding may have a material adverse effect on its business, results of operations and financial condition.

2. Any manufacturing or quality control problems may disrupt its business operations, damage the company reputation for high quality production and expose it to potential litigation or other liabilities, which would negatively impact its business, prospects, cash flows, results of operations and financial condition.

3. The company highly depends on its major raw materials and a few key suppliers who help it procure the same. the Company has not entered into long-term agreements with its suppliers for supply of raw materials. In the event the company is unable to procure adequate amounts of raw materials, at competitive prices its business, results of operations and financial condition may be adversely affected.

4. The company conducts its business activities on a purchase order basis and therefore, has not entered into long-term agreements with its customers except government contracts.

5. Its business activities are exposed to fluctuations in the prices of raw materials.

6. If the company cannot respond adequately to the increased competition its expect to face, the company will lose market share and its profits will decline, which will adversely affect its business, results of operations and financial condition.

7. The company is required to obtain, renew or maintain certain statutory and regulatory permits and approvals required to operate its business and if the company fail to do so in a timely manner or at all and its business, financial conditions, results of operations, and cash flows may be adversely affected.

8. The Company is reliant on the demand from the pharmaceutical industry for a significant portion of its revenue. Any downturn in the pharmaceutical industry or an inability to increase or effectively manage its sales could have an adverse impact on the Company's business and results of operations.

9. Continued operations of its manufacturing facility are critical to the company business and any disruption in the operation of its manufacturing facility may have a material adverse effect on its business, results of operations and financial condition.

10. Majority of its revenue is dependent on two products i.e., ORS Powder and Liquid Orals, if the company is unable to anticipate or adapt to evolving upgradation of products or inability to ensure product quality or reduction in the demand of such products may adversely impact its revenue from operations and growth prospects.

Why should you invest in

-

Financials

Particulars For the financial year ending (in ₹ million)
  2024 2023 2022
Total Assets 135.04 97.92 68.58
Total Liabilities 135.04 97.92 68.58
Total Expenses 119 109.1 88.26
Total Revenue 
133.74 115.76 92.67
Profit After Tax 9.59 4.88 3.14
EBITDA 17.74 10.29 7.84
Adjusted EBITDA 0 0 0

Zenith Drugs Ltd IPO Listing Details

Listing Date BSE Script Code NSE Symbol ISIN Final Issue Price
2024-02-27 92356 ZENITHDRUG
INE0QWN01013
₹79 per share

Listing Day Trading Information

Price Details BSE NSE
Final Issue Price ₹79 ₹79
Open ₹0 ₹110
Low ₹0 ₹104.5
High ₹0 ₹114.5
Low ₹0 ₹104.5

Frequently Asked Questions

What is Zenith Drugs Ltd IPO?

Answer Field

Zenith Drugs Ltd IPO is a SME IPO of 51,48,800 equity shares of a face value of ₹10 aggregating up to ₹40.68 Crores. The issue is priced at ₹79 to ₹79 per share. The minimum order quantity is 1600 Shares. The IPO opens on February 19, 2024, and closes on February 22, 2024. Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on NSE-SME.

When Zenith Drugs Ltd IPO will open?

Answer Field

The Zenith Drugs Ltd IPO opens on February 19, 2024 and closes on February 22, 2024.

What is the lot size of Zenith Drugs Ltd?

Answer Field

Zenith Drugs Ltd lot size is 1600 shares, and the minimum amount required is ₹1,26,400.

How to apply for Zenith Drugs Ltd IPO?

Answer Field

You can apply in Zenith Drugs Ltd IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. To apply for an IPO:

• Login to Bajaj Broking account App/Website & click on IPO

• Enter the number of lots and price at which you wish to apply.

• Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange.

• You will receive a mandate notification to block funds in your UPI app.

• Approve the mandate request on your UPI and funds will be blocked.

When is Zenith Drugs Ltd IPO allotment?

Answer Field

The finalization of Basis of Allotment for Zenith Drugs Ltd IPO will be done on February 23, 2024, and the allotted shares will be credited to your demat account by February 26, 2024.

When is Zenith Drugs Ltd IPO listing date?

Answer Field

The Zenith Drugs Ltd listing date is February 27, 2024.

Who is the registrar of Zenith Drugs Ltd IPO?

Answer Field

The registrar of Zenith Drugs Ltd IPO is Bigshare Services Pvt Ltd

Which company is the book-running lead manager of the IPO?

Answer Field

Gretex Corporate Services Ltd will be the book-running lead manager of this IPO.

What is the fresh issue of Zenith Drugs Ltd IPO?

Answer Field

The fresh issue size is ₹40.68 Crores equity shares.

What minimum lot size can retail subscribers subscribe to Zenith Drugs Ltd?

Answer Field

Retail investors can subscribe to a minimum of one lot, 1600 shares and ₹1,26,400 amount.

How can I approve the UPI mandate request for Zenith Drugs Ltd IPO?

Answer Field

To apply for Zenith Drugs Ltd IPO, you need to log in to your demat account to complete the bidding process. Then, approve the payment mandate on your UPI app.

What is the price range of Zenith Drugs Ltd?

Answer Field

The price of each Zenith Drugs Ltd share will be ranging in between ₹79 to ₹79 per share.

What is the cut-off time for the UPI mandate for Zenith Drugs Ltd IPO?

Answer Field

The cut-off time for the UPI mandate confirmation is 5:00 PM, February 22, 2024.

No results found

Browse IPOs

upcoming-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
current-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • ONE MOBIKWIK SYSTEMS LIMITEDMainboard IPO

  • Bidding Dates

    11th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹265.0 - 279.0

  • IPO Size

    ₹5,72,00,00,000

  • Apply Now
  • PURPLE UNITED SALES LIMITEDSME IPO

  • Bidding Dates

    11th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹121.0 - 126.0

  • IPO Size

    ₹32,81,00,000

  • Apply Now
  • SAI LIFE SCIENCES LIMITEDMainboard IPO

  • Bidding Dates

    11th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹522.0 - 549.0

  • IPO Size

    ₹30,42,62,00,000

  • Apply Now
  • VISHAL MEGA MART LIMITEDMainboard IPO

  • Bidding Dates

    11th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹74.0 - 78.0

  • IPO Size

    ₹80,00,00,00,000

  • Apply Now
  • YASH HIGHVOLTAGE LIMITEDSME IPO

  • Bidding Dates

    12th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹138.0 - 146.0

  • IPO Size

    ₹1,10,01,00,000

  • Apply Now
  • HAMPS BIO LIMITEDSME IPO

  • Bidding Dates

    13th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹51.0 - 51.0

  • IPO Size

    ₹6,22,00,000

  • Apply Now
  • NACDAC INFRASTRUCTURE LIMITEDSME IPO Early Access

  • Bidding Dates

    17th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹33.0 - 35.0

  • IPO Size

    ₹10,01,00,000

  • Apply Now
  • NACDAC INFRASTRUCTURE LIMITEDSME IPO Early Access

  • Bidding Dates

    17th Dec 2024 - 12th Dec 2024

  • Price Range

    ₹33.0 - 35.0

  • IPO Size

    ₹10,01,00,000

  • Apply Now
closed-radio
  • IPO Name
  • Bidding Dates
  • Price range
  • IPO Size
  • Lorem Ipsum
  • SWIGGY LIMITEDMainboard IPO

  • Bidding Dates

    6th Nov 2024 - 11th Nov 2024

  • Price Range

    ₹371.0 - 390.0

  • IPO Size

    ₹1,13,27,43,00,000

  • Invest Now
performance-radio
  • IPO Name
  • ISSUE PRICE
  • LISTING DAY CLOSE
  • LISTING DAY(GAIN/LOSS)
  • Lorem Ipsum
  • NTPC GREEN ENERGY LIMITEDMainboard IPO

  • Issue Price

    108.00

  • Listing Day Close

    122.10

  • Listing Day (Gain/Loss)

    12.96

  • ONYX BIOTEC LIMITEDSME IPO

  • Issue Price

    61.00

  • Listing Day Close

    56.75

  • Listing Day (Gain/Loss)

    -6.56

  • ZINKA LOGISTICS SOLUTIONS LIMITEDMainboard IPO

  • Issue Price

    273.00

  • Listing Day Close

    260.20

  • Listing Day (Gain/Loss)

    -4.76

  • MANGAL COMPUSOLUTION LIMITEDSME IPO

  • Issue Price

    45.00

  • Listing Day Close

    42.75

  • Listing Day (Gain/Loss)

    -4.44

  • NEELAM LINENS AND GARMENTS INDIA LIMITEDSME IPO

  • Issue Price

    24.00

  • Listing Day Close

    38.05

  • Listing Day (Gain/Loss)

    58.33

  • NIVA BUPA HEALTH INSURANCE COMPANY LIMITEDMainboard IPO

  • Issue Price

    74.00

  • Listing Day Close

    74.00

  • Listing Day (Gain/Loss)

    0.00

  • SWIGGY LIMITEDMainboard IPO

  • Issue Price

    390.00

  • Listing Day Close

    455.95

  • Listing Day (Gain/Loss)

    16.92

  • ACME SOLAR HOLDINGS LIMITEDMainboard IPO

  • Issue Price

    289.00

  • Listing Day Close

    253.50

  • Listing Day (Gain/Loss)

    -12.11

  • SAGILITY INDIA LIMITEDMainboard IPO

  • Issue Price

    30.00

  • Listing Day Close

    29.36

  • Listing Day (Gain/Loss)

    -3.33

  • AFCONS INFRASTRUCTURE LIMITEDMainboard IPO

  • Issue Price

    463.00

  • Listing Day Close

    474.55

  • Listing Day (Gain/Loss)

    2.59

  • USHA FINANCIAL SERVICES LIMITEDSME IPO

  • Issue Price

    168.00

  • Listing Day Close

    155.85

  • Listing Day (Gain/Loss)

    -7.14

  • GODAVARI BIOREFINERIES LIMITEDMainboard IPO

  • Issue Price

    352.00

  • Listing Day Close

    342.85

  • Listing Day (Gain/Loss)

    -2.56

  • OBSC PERFECTION LIMITEDSME IPO

  • Issue Price

    100.00

  • Listing Day Close

    115.50

  • Listing Day (Gain/Loss)

    16.00

  • UNITED HEAT TRANSFER LIMITEDSME IPO

  • Issue Price

    59.00

  • Listing Day Close

    63.95

  • Listing Day (Gain/Loss)

    8.47

  • DANISH POWER LIMITEDSME IPO

  • Issue Price

    380.00

  • Listing Day Close

    598.50

  • Listing Day (Gain/Loss)

    57.63

  • WAAREE ENERGIES LIMITEDMainboard IPO

  • Issue Price

    1503.00

  • Listing Day Close

    2336.80

  • Listing Day (Gain/Loss)

    55.49

  • DEEPAK BUILDERS AND ENGINEERS INDIA LIMITEDMainboard IPO

  • Issue Price

    203.00

  • Listing Day Close

    161.90

  • Listing Day (Gain/Loss)

    -20.20

  • PREMIUM PLAST LIMITEDSME IPO

  • Issue Price

    49.00

  • Listing Day Close

    48.90

  • Listing Day (Gain/Loss)

    0.00

  • FRESHARA AGRO EXPORTS LIMITEDSME IPO

  • Issue Price

    116.00

  • Listing Day Close

    134.70

  • Listing Day (Gain/Loss)

    16.38

  • LAKSHYA POWERTECH LIMITEDSME IPO

  • Issue Price

    180.00

  • Listing Day Close

    359.10

  • Listing Day (Gain/Loss)

    99.44

We have something for everyone

Explore more Investment options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Related Articles

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

8 Lacs+ Users

icon-with-text

4.4+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4700+ Cr MTF Book

icon-with-text